Allele-Specific Chemical Genetics: Concept, Strategies, and Applications

Abstract

The relationship between DNA and protein sequences is well understood, yet because the members of a protein family/subfamily often carry out the same biochemical reaction, elucidating their individual role in cellular processes presents a challenge. Forward and reverse genetics have traditionally been employed to understand protein functions with considerable success. A fundamentally different approach that has gained widespread application is the use of small organic molecules, known as chemical genetics. However, the slow time-scale of genetics and inherent lack of specificity of small molecules used in chemical genetics have limited the applicability of these methods in deconvoluting the role of individual proteins involved in fast, dynamic biological events. Combining the advantages of both the techniques, the specificity achieved with genetics along with the reversibility and tunability of chemical genetics, has led to the development of a powerful approach to uncover protein functions in complex biological processes. This technique is known as allele-specific chemical genetics and is rapidly becoming an essential toolkit to shed light on proteins and their mechanism of action. The current review attempts to provide a comprehensive description of this approach by discussing the underlying principles, strategies, and successful case studies. Potential future implications of this technology in expanding the frontiers of modern biology are discussed.

Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure–activity relationships studies

“…brain fog, neurodegeneration, and other CNS pathologies (Yamauchi et al, 2012;Kombo and Bencherif, 2013;Rankovic, 2015). Regrettably, relatively little consideration has concentrated on the development of a7 nAChR antagonists as potential pharmaceutical candidates, even though a7 nAChR selective antagonists have been believed to be useful in the medication of neuropathology and complaint (Garcia-Delgado et al, 2010;Crestey et al, 2013;Islam, 2015). Thus, the development of selective a7 nAChR antagonists is certainly a new research area in medicinal chemistry.…”

Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis via SYK activation

“…In this report, we present a novel chemical genetics strategy to acutely modulate kinase activity and visualize kinase target engagement, combining precise gene editing with the design and application of complementary covalent inhibitors. The field of chemical genetics has previously generated tools to aid in kinase target validation 54,55 , such as the powerful "analog-sensitive" (AS) technology, where the gatekeeper residue is changed into a less bulky residue, enabling the kinase of interest to accommodate bulky ATP analogs in its active site. 56 However, these analogs do not form covalent adducts with the kinase and therefore do not readily allow visualization of target engagement.…”

Engineered kinesin motor proteins amenable to small molecule inhibition

“…Chemical-genetic approaches have been successfully used to study the function of proteins for which the identification of specific inhibitors has remained elusive 36,37 . For ATPases such as kinases or motor proteins (including myosins and kinesins), such approaches have involved enlargement of the ATP binding pocket to accommodate a nucleotide or inhibitor analogue that contains a bulky substituent complementing the enlarged pocket.…”